The aim of the study is to assess the effect of therapy with canagliflozin and metformin on carbohydrate and fat metabolism in patients with type 2 diabetes mellitus and visceral obesity. Methods . A total of 20 patients with diabetes mellitus and visceral obesity with poor

Obesity is one of the most common chronic diseases requiring long-term combination therapy. This pathology is a risk factor for the development of diabetes, as well as cardiovascular diseases such as hypertension, coronary heart disease, chronic heart failure. Most often,

The article considers the observed increase in chronic pathology in children and adolescents, which requires close attention to their reproductive health. The aim of the work is to assess the structure and frequency of detection of General reproductive pathology in puberal

According to the WHO, there are currently about 422 million people worldwide have diabetes mellitus. The rapid increase in the incidence of diabetes has led to an increase in the number of people with disabilities. In 2016 1.6 million deaths were caused by diabetes. This

Nowadays there are 4.5 million patients with diabetes in Russia, and 92.1% of cases are type 2 diabetes mellitus. According to the Federal Register of Diabetic Patients, only 75.2% of them take glucose-lowering therapy. Despite the rapid development of diabetology and the

The review is devoted to the history and results of the work of Acromegaly Consensus Group, connected with the improvement of laboratory and instrumental diagnostics of acromegaly, the introduction of advanced methods of medical management of acromegaly. Optimal use of

X-linked adrenoleukodystrophy (X-ALD) was first described by S. HaberfeLd, H. Spieler in 1910. X-ALD is a rare hereditary disease with X-linked recessive inheritance; its development is due to the different mutation variants of the ABCD1 gene (Xq28), which is responsible for